Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Tyring

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Archives of Dermatology|November 11, 1992
Treatment of cutaneous squamous cell carcinomas by intralesional interferon alfa-2b therapyL Edwards, B Berman, R P Rapini, et al.
The British Journal of Dermatology|June 14, 2005
A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reductionK A Papp, S Tyring, M Lahfa, et al.
Annals of Internal Medicine|September 1, 1996
Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study GroupR J Whitley, H Weiss, J W Gnann, et al.
Archives of Dermatology|February 5, 1998
Safety and efficacy of 0.5% podofilox gel in the treatment of anogenital wartsS Tyring, L Edwards, L K Cherry, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 20, 2021
Quality of life and patient-perceived symptoms in patients with psoriasis undergoing proactive or reactive management with the fixed-dose combination Cal/BD foam: A post-hoc analysis of PSO-LONGA Jalili, P Calzavara-Pinton, L Kircik, et al.
The British Journal of Dermatology|March 29, 2019
The oral Janus kinase/spleen tyrosine kinase inhibitor ASN002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate-to-severe atopic dermatitis: results from a randomized double-blind placebo-controlled studyR Bissonnette, C Maari, S Forman, et al.
JAMA|August 4, 1999
Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study GroupL Corey, A G Langenberg, R Ashley, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Archives of Dermatology|November 11, 1992
Treatment of cutaneous squamous cell carcinomas by intralesional interferon alfa-2b therapyL Edwards, B Berman, R P Rapini, et al.
The British Journal of Dermatology|June 14, 2005
A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reductionK A Papp, S Tyring, M Lahfa, et al.
Annals of Internal Medicine|September 1, 1996
Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study GroupR J Whitley, H Weiss, J W Gnann, et al.
Archives of Dermatology|February 5, 1998
Safety and efficacy of 0.5% podofilox gel in the treatment of anogenital wartsS Tyring, L Edwards, L K Cherry, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 20, 2021
Quality of life and patient-perceived symptoms in patients with psoriasis undergoing proactive or reactive management with the fixed-dose combination Cal/BD foam: A post-hoc analysis of PSO-LONGA Jalili, P Calzavara-Pinton, L Kircik, et al.
The British Journal of Dermatology|March 29, 2019
The oral Janus kinase/spleen tyrosine kinase inhibitor ASN002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate-to-severe atopic dermatitis: results from a randomized double-blind placebo-controlled studyR Bissonnette, C Maari, S Forman, et al.
JAMA|August 4, 1999
Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study GroupL Corey, A G Langenberg, R Ashley, et al.
Pageof 4